Ziv Aflibercept

Drug Index

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

NDC Database

Zaltrap 200 mg/8ml Intravenous Solution, Concentrate by Sanofi-aventis U.S. LLC ## Package Codes: 0024-5841-01 ## Active Ingredients: Ziv-aflibercept

NDC Database

Zaltrap 100 mg/4ml Intravenous Solution, Concentrate by Sanofi-aventis U.S. LLC ## Package Codes: 0024-5840-01, 0024-5840-03 ## Active Ingredients: Ziv-aflibercept